RecruitingNCT05804240

TEE 3D RV Assessment for SAVR, Mini AVR, and TAVR

Utility of Three-dimensional Transesophageal Echocardiography in Right Ventricular Function Assessment in Surgical Aortic Valve Replacement, Mini-sternotomy Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement


Sponsor

Thomas Jefferson University

Enrollment

78 participants

Start Date

Apr 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Three-dimensional echocardiography has become a gold standard to assess right ventricular (RV) function, and investigators plan to use 3D transesophageal echocardiography to assess RV function in 3 types of aortic valve replacement (AVR): surgical AVR (SAVR), mini-sternotomy AVR (mini AVR), and transcatheter AVR (TAVR).


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Adult patients over 18 years old
  • Patients who had SAVR, mini AVR, or TAVR

Exclusion Criteria2

  • Patients' refusal
  • Suboptimal echocardiography data for RVEF, RV size, RIMP, RVFAC, TAPSE, S', STE

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TEST3D TEE RVEF

With TEE package software, the investigators measure and calculate 3D TEE RVEF using mid esophageal 4 chamber view


Locations(1)

Thomas Jefferson University

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05804240


Related Trials